MARATTO

article · Moscow University Physics Bulletin

Characterization of Secondary Neutron Spectra from Therapeutic Proton and Carbon Ion Beams Using PHITS Simulation

20232 citationsIbn Tofail University

Abstract

Hadron therapy (HT) is a technique that uses accelerated ions, notably protons, and carbon ions, to destroy tumors. It has demonstrated high success rates in the treatment of certain cancers resistant to irradiation. In HT, the majority of the dose is delivered to the tumor volume by electromagnetic interactions with atomic electrons. However, it is important to note that the primary particles used in HT can induce nuclear reactions, generating undesirable secondary radiation, certainly neutrons. As a result, a significant portion of the patients’ body may be exposed to the secondary background radiation field. Thus, these unwanted secondary neutrons should be evaluated. The purpose of this research in first is to characterize the secondary neutron production (SNP) during the administration of Hadrons with energies 140 MeV proton, and 264 MeV/u carbon ions ( $${}^{12}$$ C) in a soft tissue phantom. Second, comparing the neutron spectrum for different angles for protons and carbon ions for carbon targets to experimental data. Our results show that the neutron spectra (thick target neutron yields TTNYs ) at energies less than $$\thickapprox$$ 20 MeV, using the INCL4.6/GEM models and JQMD/GEM across a wide range would be suitable for the Monte Carlo transport simulation.

Research topics

  • Radiation Therapy and Dosimetry
  • Nuclear Physics and Applications
  • Radiation Detection and Scintillator Technologies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3103/s0027134923060036

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.